GB1256914A - - Google Patents

Info

Publication number
GB1256914A
GB1256914A GB1256914DA GB1256914A GB 1256914 A GB1256914 A GB 1256914A GB 1256914D A GB1256914D A GB 1256914DA GB 1256914 A GB1256914 A GB 1256914A
Authority
GB
United Kingdom
Prior art keywords
extract
iboga
alkaloid
jan
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1256914A publication Critical patent/GB1256914A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
GB1256914D 1968-01-31 1969-01-30 Expired GB1256914A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR138081A FR7131M (fr) 1968-01-31 1968-01-31

Publications (1)

Publication Number Publication Date
GB1256914A true GB1256914A (fr) 1971-12-15

Family

ID=8645336

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1256914D Expired GB1256914A (fr) 1968-01-31 1969-01-30

Country Status (5)

Country Link
BE (1) BE726760A (fr)
CA (1) CA939266A (fr)
DE (1) DE1902227A1 (fr)
FR (1) FR7131M (fr)
GB (1) GB1256914A (fr)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261977A2 (fr) * 1986-09-26 1988-03-30 MITSUI TOATSU CHEMICALS, Inc. Dérivés du catéchol et préparations préventives et médicinales pour le traitement de troubles régressifs dans le système nerveux central
EP0511325A1 (fr) * 1990-05-31 1992-11-04 Nda International, Inc. Procede rapide d'interruption ou d'attenuation des syndromes de dependance polydrogues
US5214034A (en) * 1986-09-26 1993-05-25 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
EP1383465A2 (fr) * 2001-03-29 2004-01-28 Emory University Augmentation accrue de la psychotherapie par voie pharmacologique, avec un activateur d'apprentissage ou de conditionnement
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US7754710B2 (en) 1997-09-04 2010-07-13 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8859764B2 (en) 2011-01-26 2014-10-14 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9051343B2 (en) 2011-12-09 2015-06-09 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9358237B2 (en) 2010-07-23 2016-06-07 Demerx, Inc. Noribogaine compositions
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857523A (en) * 1988-07-18 1989-08-15 Nda International, Inc. Rapid method for attenuating the alcohol dependency syndrome
US9561233B2 (en) 2014-03-13 2017-02-07 Demerx, Inc. Use of ibogaine for the treatment of pain
US9592239B2 (en) 2014-09-12 2017-03-14 Demerx, Inc. Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261977A2 (fr) * 1986-09-26 1988-03-30 MITSUI TOATSU CHEMICALS, Inc. Dérivés du catéchol et préparations préventives et médicinales pour le traitement de troubles régressifs dans le système nerveux central
EP0261977A3 (en) * 1986-09-26 1989-04-05 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system
US5214034A (en) * 1986-09-26 1993-05-25 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
EP0511325A1 (fr) * 1990-05-31 1992-11-04 Nda International, Inc. Procede rapide d'interruption ou d'attenuation des syndromes de dependance polydrogues
EP0511325A4 (en) * 1990-05-31 1993-02-03 Nda International, Inc. A rapid method for interrupting or attenuating poly-drug dependency syndromes
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US7754710B2 (en) 1997-09-04 2010-07-13 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US8178524B2 (en) 1997-09-04 2012-05-15 Demerx, Inc. Noribogaine in the treatment of pain and drug addiction
EP1383465A2 (fr) * 2001-03-29 2004-01-28 Emory University Augmentation accrue de la psychotherapie par voie pharmacologique, avec un activateur d'apprentissage ou de conditionnement
EP1383465A4 (fr) * 2001-03-29 2009-04-15 Univ Emory Augmentation accrue de la psychotherapie par voie pharmacologique, avec un activateur d'apprentissage ou de conditionnement
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9308272B2 (en) 2010-06-22 2016-04-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US9358237B2 (en) 2010-07-23 2016-06-07 Demerx, Inc. Noribogaine compositions
US8859764B2 (en) 2011-01-26 2014-10-14 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9403817B2 (en) 2011-01-26 2016-08-02 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
US9051343B2 (en) 2011-12-09 2015-06-09 Demerx, Inc. Phosphate esters of noribogaine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9469649B2 (en) 2012-01-25 2016-10-18 Demerx, Inc. Synthetic voacangine
US8877921B2 (en) 2012-01-25 2014-11-04 Demerx, Inc. Synthetic voacangine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Also Published As

Publication number Publication date
CA939266A (en) 1974-01-01
BE726760A (fr) 1969-06-16
FR7131M (fr) 1969-07-21
DE1902227A1 (de) 1969-09-04

Similar Documents

Publication Publication Date Title
GB1256914A (fr)
GB1434724A (en) Spasmolytic medicines comprising a vidiquil derivative
GB1168738A (en) Benzimidazole Derivatives and their preparation and use
ES341109A1 (es) Metodo para la preparacion de nuevas sales basicas de adi- cion de acido ribonucleico.
EP0210430A3 (fr) Utilisation du tyrosine pour l'amélioration de la fertilité chez les mammifères
Arluck Hypnoanalysis: A case study.
GB1141735A (en) Pharmaceutical anti-tumor composition
ES377523A1 (es) Un procedimiento para fabricar una sustancia combinada, compuesta de acido germanico y cisteina.
USD186330S (en) Bicycle headlight
JPS5278327A (en) Semiconductor memory
USD191577S (en) Combined mounting bracket and railing post
USD223664S (en) Earth bar
USD202147S (en) Water filter unit
GB1206901A (en) A flux for zincking, tinning and leading
USD192192S (en) Combined pitcher and dispensing closure
GR37429B (el) Μεθοδος παρασκευης τριυδρικης αμπικιλλινης.
GB1283505A (en) Substituted alkanol-thioalkyl-amines
JPS5223095A (en) Preparation of purinenucleotides
USD218731S (en) Bottle
IE33519L (en) Benzylhydrazides
Wehrell Heidegger's ontological framework of'existentiell possibility,''authenticity'and'inauthenticity'as a solution to the problem of uniqueness in the logic of historiographical explanation
Shader Behavioral treatment of enuresis nocturna.
GB1395929A (en) Thioureas
FR2269932A1 (en) Synergistic hypotensive compsns for oral admin - contg reserpine and guancydine
GB1199914A (en) Freeze Concentration of Coffee

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee